Skip to content

assessment of Jalakumbhi Panchanga Bhasma along with Pippali Churna in the patients of Hypothyriodism

A Clinical Study of Jalakumbhi Panchanga Bhasma along with Pippali Churna in the Cases of Hypothyriodism

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045725
Enrollment
70
Registered
2022-09-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E039- Hypothyroidism, unspecified

Interventions

None listed

Sponsors

Department of Kayachiktsa Faculty of Ayurveda Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Willing to give consent to participate in the study. 2. Patients in age group between 30-60 years of either sex. 3. Patients positive for Zulewskiââ?¬•s clinical score for hypothyroidism. 4. Patient fulfilling the laboratory diagnosis of hypothyroidism on the basis of serum TSH, T3 and T4 levels. 5. Patients having uncontrolled TSH level in spite adequate doses of Levothyroxine.

Exclusion criteria

Exclusion criteria: 1. Patients age 60 years. 2. Patients with ischemic heart disease, uncontrolled hypertension, myocardial infarction, cerebrovascular event, cardiac arrhythmias, pregnancy and active malignant disease were excluded from the study. 3. Patients with altered thyroid hormone levels due to other conditions such as undernutrition, malignant neoplasm or non-thyroidal illness (low-T3 syndrome).

Design outcomes

Primary

MeasureTime frame
1.Thyroid profile 2.Lipid profile 3.Complete blood countTimepoint: Before drug trail and after drug trail i.e.,after 3 months

Secondary

MeasureTime frame
Agni assessmentTimepoint: Three month before and after trail;WHO QOL BreifTimepoint: Three month before and after trail

Countries

India

Contacts

Public ContactDr Ajai Kumar Pandey

Banaras Hindu University

drajaipandey@gmail.com9452827885

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026